| 摘要 |
FIELD: medicine.SUBSTANCE: group of inventions refers to using the inhibitor of chloride ion transport to neurons which represents bumetanide, a Na-K-Cl co-transporter inhibitor, or bumetanide aldehyde, bumetanide dibenzylamide, bumetanide diethylamide, bumetanide morpholinoethyl ester, bumetanide 3-dimethylaminopropyl ester, bumetanide N,N-diethylglycolamide ester, bumetanide dimethylglycolamide ester, bumetanide pivaxetil ester, bumetanide methoxy-(polyethylenoxy)n-i-ethyl ester, bumetanide benzyltrimethyl ammonium salt and bumetanide cetyltrimethyl ammonium salt for treating autism, and to using the based pharmaceutical composition.EFFECT: efficacy in accordance with the claimed application with no adverse side effects.3 cl, 2 tbl |
